Medicare Enrolled

Dr. Jeffrey Rothman, MD

Endocrinology · Staten Island, NY
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
1460 VICTORY BLVD, Staten Island, NY 10301
7184420300
In practice since 2005 (20 years)
NPI: 1811982812 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Rothman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Rothman? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Rothman

Dr. Jeffrey Rothman is an endocrinology specialist in Staten Island, NY, with 20 years of NPI registration. Based on federal Medicare data, Dr. Rothman performed 1,184 Medicare services across 985 unique beneficiaries.

Between the years covered by Open Payments, Dr. Rothman received a total of $6,363 from 43 pharmaceutical and/or device companies across 364 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Rothman is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 37% volume in NY $6,363 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,184
Medicare services
Top 37% in NY for endocrinology
985
Unique beneficiaries
$46
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~59 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Bone density scan (DEXA)
A test that uses low-dose X-rays to measure bone mineral density in the hip, pelvis, and spine. It helps assess bone strength and risk of fractures.
502 $10 $29
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
274 $69 $214
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
226 $97 $314
Ultrasound of head and neck soft tissue
This procedure uses sound waves to create images of the soft tissues in the head and neck area. It allows for the visualization of structures beneath the skin without using radiation.
84 $89 $371
Blood glucose test using hand-held instrument
A test that measures the level of sugar in the blood using a portable device. The result helps monitor blood glucose levels.
59 $3 $15
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
39 $12 $76
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$6,363
Total received (2018-2024)
Avg $909/year across 7 years
Top 25% in NY for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
43
Companies
364
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,363 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$95
2023
$846
2022
$1,109
2021
$909
2020
$1,216
2019
$1,034
2018
$1,153

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Abbott Laboratories
$48
Amphastar Pharmaceuticals, Inc.
$19
Mannkind Corporation
$14
CeQur Corporation
$14
Top 3 companies account for 85.5% of 2024 payments
All-time payments by company (2018-2024) ›
Novo Nordisk Inc
$1,165
Amgen Inc.
$827
AstraZeneca Pharmaceuticals LP
$606
Abbott Laboratories
$502
Radius Health, Inc.
$433
Janssen Pharmaceuticals, Inc
$351
Amneal Pharmaceuticals LLC
$331
Merck Sharp & Dohme Corporation
$293
Medtronic MiniMed, Inc.
$292
AbbVie Inc.
$238
Lilly USA, LLC
$223
ABBVIE INC.
$208
SANOFI-AVENTIS U.S. LLC
$74
MannKind Corporation
$74
Dexcom, Inc.
$61
DEXCOM, INC.
$58
Celgene Corporation
$52
AbbVie, Inc.
$44
Ascendis Pharma Inc
$43
Corcept Therapeutics
$39
Shire North American Group Inc
$32
Boehringer Ingelheim Pharmaceuticals, Inc.
$32
Mannkind Corporation
$31
Merck Sharp & Dohme LLC
$31
CeQur Corporation
$28
Ultragenyx Pharmaceutical Inc.
$23
Amryt Pharma Holdings Ltd
$22
OPKO Pharmaceuticals, LLC
$20
Xeris Pharmaceuticals, Inc.
$19
Amphastar Pharmaceuticals, Inc.
$19
Bayer HealthCare Pharmaceuticals Inc.
$17
Valeritas, Inc.
$17
Medtronic, Inc.
$16
Tolmar, Inc.
$16
Strongbridge US INC.
$15
VistaPharm, Inc.
$15
IBSA Pharma Inc.
$15
LifeScan, Inc.
$14
Sanofi Pasteur Inc.
$14
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$14
Advanced Oxygen Therapy Inc.
$14
PFIZER INC.
$12
Regeneron Healthcare Solutions, Inc.
$11
Top 3 companies account for 40.8% of all-time payments
Associated products mentioned in payments ›
AFREZZA · ASMANEX · CRYSViTA · CYCLOSET · CeQur Simplicity · DEXCOM G6 TRANSMITTER · Dexcom G6 Transmitter · EVENITY · FARXIGA · FLUZONE HIGH-DOSE · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre · FreeStyle Libre 2 · FreeStyle Libre Pro · FreeStyle Libre blood glucose Flash Monitoring System · GVOKE PFS · INVOKANA · JANUVIA · JARDIANCE · JATENZO · Kerendia · Korlym · LYUMJEV · Levemir · MACRILEN · MOUNJARO · MYCAPSSA · Minimed 670G System · Minimed 770G System · NATPARA · Norditropin · OneTouch · Ozempic · PRALUENT ALIROCUMAB INJECTION · Prolia · RETEVMO · RYBELSUS · Rayaldee · Rybelsus · SOLIQUA · SOLIQUA 100/33 · SOMAVERT · STEGLATRO · STEGLUJAN · SYNTHROID · Saxenda · Sogroya · Synthroid · TOUJEO · TRADJENTA · TRULICITY · TZIELD · Thyquidity · Tirosint · Tresiba · Tymlos · UNITHROID · V-GO · Victoza · XARELTO
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an endocrinology specialist in Staten Island?
Compare endocrinologists in the Staten Island area by procedure volume, costs, and industry payment transparency.
Browse endocrinologists nearby

Geographic Context

Endocrinologists within 10 mi
664
Per 100K population
134.8
County median income
$98,290
Nearest hospital
RICHMOND UNIVERSITY MEDICAL CENTER
1.2 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Rothman is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Rothman experienced with bone density scan (dexa)?
Based on Medicare claims data, Dr. Rothman performed 502 bone density scan (dexa) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Rothman receive payments from pharmaceutical companies?
Yes. Dr. Rothman received a total of $6,363 from 43 companies across 364 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Rothman's costs compare to other endocrinologists in Staten Island?
Dr. Rothman's average Medicare payment per service is $46. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Rothman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →